Prothena Corporation PLC
PRTA6.940USD
+0.130+1.91%
Cierre 08/04, 16:00（ET）Cotizaciones retrasadas 15 min
373.56MCap. mercado
PérdidaP/E TTM
Más Datos de Prothena Corporation PLC Compañía
Prothena Corporation plc is an Ireland-based late-stage clinical biotechnology company. The Company is engaged in protein dysregulation and a pipeline of investigational therapeutics for rare peripheral amyloid diseases. The Company is advancing a pipeline of therapeutic candidates for a range of indications and targets to integrate scientific insights around neurological dysfunction and the biology of misfolded proteins. The Company’s pipeline includes both wholly owned and partnered programs being developed for the potential treatment of diseases, including AL amyloidosis, ATTR amyloidosis, Alzheimer’s disease, Parkinson’s disease and a range of other neurodegenerative diseases. Its clinical programs include birtamimab for the potential treatment of AL amyloidosis, prasinezumab for the potential treatment of Parkinson’s disease, NNC6019/PRX004 for the potential treatment of ATTR amyloidosis, and PRX005 and PRX012 for the potential treatment of Alzheimer’s disease.
Información de la empresa
Símbolo de cotizaciónPRTA
Nombre de la empresaProthena Corporation PLC
Fecha de salida a bolsaDec 21, 2012
Director ejecutivoDr. Gene G. Kinney, Ph.D.
Número de empleados163
Tipo de seguridadOrdinary Share
Fin del año fiscalDec 21
Dirección77 Sir John Rogerson's Quay, Block C
CiudadDUBLIN
Bolsa de valoresNASDAQ Global Select Consolidated
PaísIreland
Código postalD02 VK60
Teléfono35312362500
Sitio Webhttps://www.prothena.com/
Símbolo de cotizaciónPRTA
Fecha de salida a bolsaDec 21, 2012
Director ejecutivoDr. Gene G. Kinney, Ph.D.
Ejecutivos de la empresa
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Brandon S. Smith
Mr. Brandon S. Smith
Chief Operating Officer
Chief Operating Officer
130.00K
--
Dr. Wagner M. Zago, Ph.D.
Dr. Wagner M. Zago, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
85.00K
--
Dr. Dennis J. Selkoe, M.D.
Dr. Dennis J. Selkoe, M.D.
Independent Director
Independent Director
4.21K
--
Mr. Richard T. Collier
Mr. Richard T. Collier
Independent Director
Independent Director
1.22K
--
Dr. Lars G. Ekman, M.D., Ph.D.
Dr. Lars G. Ekman, M.D., Ph.D.
Chairman Emeritus
Chairman Emeritus
243.00
--
Mr. Daniel G. Welch
Mr. Daniel G. Welch
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Shane M. Cooke
Mr. Shane M. Cooke
Independent Director
Independent Director
--
--
Ms. Karin L. Walker, CPA
Ms. Karin L. Walker, CPA
Chief Accounting Officer
Chief Accounting Officer
--
--
Ms. Paula K. Cobb
Ms. Paula K. Cobb
Independent Director
Independent Director
--
--
Ms. Helen S. Kim
Ms. Helen S. Kim
Independent Director
Independent Director
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Brandon S. Smith
Mr. Brandon S. Smith
Chief Operating Officer
Chief Operating Officer
130.00K
--
Dr. Wagner M. Zago, Ph.D.
Dr. Wagner M. Zago, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
85.00K
--
Dr. Dennis J. Selkoe, M.D.
Dr. Dennis J. Selkoe, M.D.
Independent Director
Independent Director
4.21K
--
Mr. Richard T. Collier
Mr. Richard T. Collier
Independent Director
Independent Director
1.22K
--
Dr. Lars G. Ekman, M.D., Ph.D.
Dr. Lars G. Ekman, M.D., Ph.D.
Chairman Emeritus
Chairman Emeritus
243.00
--
Mr. Daniel G. Welch
Mr. Daniel G. Welch
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Desglose de ingresos
Sin datos
Sin datos
Por negocio
Por región
Sin datos
Estadísticas de accionistas
Actualizado: sáb., 7 de jun
Actualizado: sáb., 7 de jun
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
Fidelity Management & Research Company LLC
14.75%
Scully (William P)
10.42%
Fennell (Todd W.)
8.53%
T. Rowe Price Associates, Inc.
6.29%
BlackRock Institutional Trust Company, N.A.
6.10%
Other
53.91%
Accionistas
Accionistas
Proporción
Fidelity Management & Research Company LLC
14.75%
Scully (William P)
10.42%
Fennell (Todd W.)
8.53%
T. Rowe Price Associates, Inc.
6.29%
BlackRock Institutional Trust Company, N.A.
6.10%
Other
53.91%
Tipos de accionistas
Accionistas
Proporción
Investment Advisor
41.72%
Individual Investor
18.99%
Hedge Fund
12.64%
Investment Advisor/Hedge Fund
10.92%
Venture Capital
5.48%
Research Firm
2.58%
Bank and Trust
0.65%
Pension Fund
0.21%
Sovereign Wealth Fund
0.11%
Other
6.70%
Participación institucional
Actualizado: mar., 1 de jul
Actualizado: mar., 1 de jul
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q2
457
50.26M
93.38%
-20.92M
2025Q1
472
64.29M
119.45%
-7.39M
2024Q4
479
65.24M
121.19%
+239.99K
2024Q3
476
59.39M
110.43%
-5.39M
2024Q2
479
58.48M
108.76%
-4.67M
2024Q1
472
60.86M
113.29%
-264.94K
2023Q4
474
56.64M
105.77%
-2.21M
2023Q3
476
55.90M
104.65%
-1.73M
2023Q2
475
55.02M
104.46%
-3.12M
2023Q1
464
54.98M
104.68%
-658.88K
Ver más
Actividad de los accionistas
Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
Fidelity Management & Research Company LLC
7.94M
14.75%
-129.91K
-1.61%
Mar 31, 2025
Scully (William P)
5.61M
10.42%
-36.34K
-0.64%
Mar 31, 2025
Fennell (Todd W.)
4.59M
8.53%
-54.34K
-1.17%
Mar 31, 2025
T. Rowe Price Associates, Inc.
3.38M
6.29%
-232.75K
-6.43%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
3.29M
6.1%
-61.73K
-1.84%
Mar 31, 2025
Logos Global Management LP
2.95M
5.48%
+2.95M
--
May 29, 2025
Armistice Capital LLC
2.20M
4.08%
-40.00K
-1.79%
Mar 31, 2025
Palo Alto Investors LP
1.66M
3.08%
-78.23K
-4.50%
Mar 31, 2025
State Street Global Advisors (US)
1.52M
2.83%
-340.28K
-18.28%
Mar 31, 2025
Invus Public Equities Advisors, LLC
1.28M
2.38%
+183.72K
+16.70%
Mar 31, 2025
Ver más
ETFs relacionados
Actualizado: sáb., 2 de ago
Actualizado: sáb., 2 de ago
Nombre
Proporción
Virtus LifeSci Biotech Clinical Trials ETF
1.08%
iShares Neuroscience and Healthcare ETF
0.63%
Invesco NASDAQ Future Gen 200 ETF
0.6%
Tema Neuroscience and Mental Health ETF
0.3%
Federated Hermes MDT Small Cap Core ETF
0.3%
ALPS Medical Breakthroughs ETF
0.22%
Invesco Nasdaq Biotechnology ETF
0.04%
iShares ESG Aware MSCI USA Small-Cap ETF
0.04%
ProShares Ultra Nasdaq Biotechnology
0.04%
iShares Biotechnology ETF
0.03%
Ver más
Virtus LifeSci Biotech Clinical Trials ETF
Proporción1.08%
iShares Neuroscience and Healthcare ETF
Proporción0.63%
Invesco NASDAQ Future Gen 200 ETF
Proporción0.6%
Tema Neuroscience and Mental Health ETF
Proporción0.3%
Federated Hermes MDT Small Cap Core ETF
Proporción0.3%
ALPS Medical Breakthroughs ETF
Proporción0.22%
Invesco Nasdaq Biotechnology ETF
Proporción0.04%
iShares ESG Aware MSCI USA Small-Cap ETF
Proporción0.04%
ProShares Ultra Nasdaq Biotechnology
Proporción0.04%
iShares Biotechnology ETF
Proporción0.03%
Dividendos
Un total de
0.00
USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos
División de acciones
Fecha
Tipo
Relación
Sin datos
Fecha
Tipo
Relación
Sin datos
